Regenex Corporation
Latest round
- Series C
Last raised
- Jun 2023
Total raised
- $14M
Investors
- 4
About Regenex Corporation
Established in 2003 and based in Guangzhou, China, Regenex Corporation operates as a reproductive health drugs developer that provides reproductive health drugs, chronic disease drugs and topical drugs. The company cooperates with Jingdong and Tmall, and establishes Langsheng reproductive health institute.,Ltd.,Ltd. In 2011, the company established R&D center. In February 2023, Dashen Lin medicine group Limited became the strategic partner of the company. The company focuses on reproductive health medicine, chronic disease medicine and topical medicine fields. Its products are divided into three series, which include male series, female series and LGBT series, such as red deer® sildenafil 100mg, danmei and hyaluronic acid lotion, etc. Technology platforms include chiral drug synthesis, injectable long-acting liposome targeted drug delivery systems, oral slow and controlled release drug delivery systems, rapid release systems for insoluble drugs and rapid analysis of complex systems.
Who invested in Regenex Corporation
4 investors across 1 round
See all investors in Regenex Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Jun 16, 2023
Amount
$14M
Investors
Questions about Regenex Corporation
Who invested in Regenex Corporation?
Regenex Corporation has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Regenex Corporation raised?
Regenex Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Regenex Corporation last raise money?
Regenex Corporation's most recent round on record is a Series C, in Jun 2023.
What does Regenex Corporation do?
Established in 2003 and based in Guangzhou, China, Regenex Corporation operates as a reproductive health drugs developer that provides reproductive health drugs, chronic disease drugs and topical drugs.
Where is Regenex Corporation headquartered?
Regenex Corporation is headquartered in Guangzhou, China.
Which VCs invest in companies like Regenex Corporation?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Regenex Corporation's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Regenex Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.